ConductScience.org, home

Paper12666

Tardive dyskinesia: are first signs reversible?

Quitkin F and 3 others. Am J Psychiatry, 1977. Cited by 110 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tardive dyskinesia: are first signs reversible? Papers, record 12666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12666

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tardive dyskinesia: are first signs reversible?
PubMed
Journal
Am J Psychiatry
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
110
iCite
Relative citation ratio, by iCite
5.83
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Quitkin FF
2Rifkin AA
3Gochfeld LL
4Klein DFD F

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Dyskinesia, Drug-InducedMajor topic
Adult
Chlorpromazine
Female
Fluphenazine
Haloperidol
Humans
Male
Middle Aged
Prognosis
Remission, Spontaneous

Source PubMed

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.

PMIDTitleJournalYearIn PapersSource
33,754,644A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.Schizophr Bull2021https://conductscience.org/library/papers/33754644PubMed
33,213,556Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.CNS Spectr2022https://conductscience.org/library/papers/33213556PubMed
33,124,584Recent Advances in the Pharmacology of Tardive Dyskinesia.Clin Psychopharmacol Neurosci2020https://conductscience.org/library/papers/33124584PubMed
32,720,245Management of Tardive Syndrome: Medications and Surgical Treatments.Neurotherapeutics2020https://conductscience.org/library/papers/32720245PubMed
31,040,678Overcoming barriers to effective management of tardive dyskinesia.Neuropsychiatr Dis Treat2019https://conductscience.org/library/papers/31040678PubMed
30,357,723Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.Drugs Aging2018https://conductscience.org/library/papers/30357723PubMed
29,409,162Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29409162PubMed
25,374,768Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic.Tremor Other Hyperkinet Mov (N Y)2014https://conductscience.org/library/papers/25374768PubMed
21,289,825The management of neuroleptic-induced CNS effects.Can Fam Physician1981https://conductscience.org/library/papers/21289825PubMed
7,047,137Management of tardive dyskinesia: current update.Drugs1982https://conductscience.org/library/papers/7047137PubMed
6,110,535Adverse effects of antipsychotic agents.Drugs1981https://conductscience.org/library/papers/6110535PubMed
381,595Six month evaluation of thiopropazate hydrochloride in tardive dyskinesia.J Neurol Neurosurg Psychiatry1979https://conductscience.org/library/papers/381595PubMed
280,396What's new in the psychopharmacology of schizophrenia.Bull N Y Acad Med1978https://conductscience.org/library/papers/280396PubMed
32,574Dopaminergic supersensitivity after neuroleptics: time-course and specificity.Psychopharmacology (Berl)1978https://conductscience.org/library/papers/32574PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12666

GET https://conductscience.org/api/papers/v1/12666/authors